Three-day or ten-day ATG treatment for steroid-resistant rejection in kidney transplanted patients.
Olausson
M
M
Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.
Mjörnstedt
L
L
Blohmé
I
I
D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006084:Graft Rejection / Q000209:etiology / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology*; D013256:Steroids / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors
D000961:Antilymphocyte Serum; D013256:Steroids